alexa
Reach Us +1 702 553-3066
Tubulocystic Carcinoma of the Kidney With Multiple Focal Clear Cell Characteristics in a Young Male: A Case Report | OMICS International
ISSN: 2157-2518
Journal of Carcinogenesis & Mutagenesis

Like us on:

Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business

Tubulocystic Carcinoma of the Kidney With Multiple Focal Clear Cell Characteristics in a Young Male: A Case Report

Shan Zheng1, Kao-Peng Guan2, Dong Qu3, Peng Cao1, Chang-Yuan Guo1, You-Yan Guan2, Chang-ling Li2 and Jian-Hui Ma2*

1Department of Pathology, Cancer Institute and Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

2Department of Urology, Cancer Institute and Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing, China

3Department of Imaging diagnosis, Cancer Institute and Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing, China

*Corresponding Author:
Jian-hui Ma
Department of Urology, Cancer Institute and Hospital
Chinese Academy of Medical Sciences and Peking Union Medical College
P.O. Box 2258 Beijing 100021, P.R.China
Tel: 86-10-87788500
Fax: 86-10-87715889
E-mail: [email protected]

Received date: November 24, 2014; Accepted date: January 21, 2015; Published date: January 25, 2015

Citation: Zheng S, Guan KG, Qu D, Cao P, Guo CY, et al. (2015) Tubulocystic Carcinoma of the Kidney With Multiple Focal Clear Cell Characteristics in a Young Male: A Case Report. J Carcinog Mutagen 6:213. doi:10.4172/2157-2518.1000213

Copyright: © 2015 Zheng S, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Carcinogenesis & Mutagenesis

Abstract

Tubulocystic carcinoma of the kidney is a rare entity, which are with about 100 cases of these tumors of the kidney all over the world. We have reported a case, of a 43-year-old man who presented with a lump in the right kidney on image examination without other complaints. Final pathologic diagnosis was tubulocystic carcinoma of the kidney with multiple focal clear cells. Six months after the procedure, the patient remained free of disease. This case showed an indolent manner a low-grade malignancy with favorable prognosis in a short-time follow-up.

Keywords

Tubulocystic carcinoma; Kidney

Abbreviation

AMACR: Alpha-Methylacyl-CoA Racemase; TC: Tubulocystic Carcinoma; MRI: Magnetic Resonance Imaging; WHO: World Health Organization

Introduction

Tubulocystic carcinoma (TC) of the kidney is a rare tumor which may be recommended to list in the next edition of World Health Organization (WHO) classification in kidney tumor [1]. The clinical, pathological, immunohistochemistrical characters of this tumor were first summarized systematically by MacLennan and his colleagues [2,3]. Now, there were about 100 cases of TC of the kidney all over the world. Here, we reported a case of TC with multiple focal clear cells in China.

Case Presentation

A 43-year-old male presented with a lump in the right kidney on Magnetic Resonance Imaging (MRI) examination without other complaints. His past medical history and family history was unremarkable. The patient’s physical exam was negative. A 1.5 cm, solid, non-enhancing mass located in the outside of the upper pole in the right kidney in Magnetic Resonance Imaging (MRI) (Figure 1). Additional workup for metastatic disease was negative. Preoperative diagnosis considered that the mass might be angiomyolipoma or and small renal cell carcinoma were all possible. The patient was underwent partial nephrectomy. No adjuvant therapy was administered to the patient. Six months after the procedure, the patient remained free of disease.

carcinogenesis-mutagenesis-small-mass

Figure 1: Magnetic Resonance Imaging showed a small mass in the outside of the upper pole in the right kidney. A, Fat Suppression T2-weighted imaging showed a high signal mass measured 1.5- ×1.4-cm, which was not homogeneous inside the mass. B, Enhancement showed the mass was not enhanced.

Gross characteristics

A wedge specimen of the kidney of 2.4-×2.0-×1.5 cm was examined sent to the department of pathology. The specimen size was 2.4×2.0×1.5 cm. The cut surface showed an ill-circumscribed solid tumor. The size of the tumor was 1.5-×1.5-×1.0 cm. The tumor involved the renal capsule.

Microscopic Characteristics

The tumors were composed of closely packed small tubules and cysts, with some slender papilla pattern (Figure 2A). The tumor grew into the surrounding normal tissue (Fig 2B). These tubules and cysts were separated by thin fibrous septa without an ovarian-type of stroma or desmoplastic reaction (Figure 2C). The epithelial cells lining the tubules and cysts were simple flat, cuboidal or hobnail cell. The cytoplasm of most cells was eosinophilic, while some cells showed clear cytoplasm (Figure 2C-2E). The lining cells showed prominent nucleoli equivalent to that of Fuhrman nuclear grade 3 (Figure 2F). There was no solid sheets growth pattern in the tumor.

carcinogenesis-mutagenesis-blue-arrow

Figure 2: The tumor is composed of small tubules and cysts, with some slender papilla pattern (A) and the boundary between tumor and normal tissue is ill-defined invasive. The red arrow showed the ill tumor’s boundary (B). Tumor cells are flat (red arrow) and cuboidal (blue arrow) with thin fibrous septa (C). Tumor cells also show high column (D, red arrow), hobnail cell (E, red arrow) or clear cytoplasm (E, blue arrow). Some tumor cells show prominent nucleoli (F, red arrow).

Immunohistochemical Features

Immunohistochemical results showed that the tumor cells were strong positive immunoreactive for the presence of CK8, CK18, CK19, CD10 and PAX8. The tumor cells were also showed positive stains associated with for alpha-methylacyl-CoA racemase (AMACR) and Vimentin, while the stains of CK7, CK34βE12, PAX2 and P53 were was focal or weak. The tumor cells showed a low Ki-67 index (Figure 3).

carcinogenesis-mutagenesis-immunohistochemistry

Figure 3: The immunohistochemistry characters of tubulocystic carcinoma of the kidney. Note the strong diffuse expression of CK8 (A), CK18 (B), CK19 (C), CD10 (D), PAX8 (E); and the middle diffuse expression of AMACR (F), Vimentin (G); and the strong focal expression of CK7 (H), CK34βE12 (I); and the weak or focal expression of PAX2 (J), P53 (K) in neoplastic cells. The Ki-67 index was very low (<5%) in neoplastic cells (L).

Discussion

We report the characteristic of a case of TC with multiple focal clear cells in China mainly focused on pathology.

Srigley et al. thought that TC was originally named “Bellinian epithelioma” in 1956 [1]. In 1997, MacLennan et al. reported 13 cases of unusual low-grade renal carcinomas with features most suggestive of collecting duct origin [2]. The latter research found that these 13 cases included two different type of renal cell carcinoma-TC and mucinous tubular and spindle cell carcinoma [3]. The latter was listed into the WHO’s classification of tumors of the urinary system and male genital organs in 2004, while the former was proposed as new epithelial neoplasms in next edition of WHO classification [1,4,5].

Most patients of TC are adults with a male predominance, while the peak age range of diagnosis is in the fifth and sixth decades [6-8]. Most patients are asymptomatic, and the majority of these patients come to the hospital with the reveal of a mass in kidney in imaging examination test [7,9,10].

Macroscopically, the tumors are well circumscribed usually, with a “bubble wrap” or “Swiss cheese” appearcance. The maximum size was no more than 5.0 cm in most cases [7,8,10-14]. Microscopically, the tumors are composed of closely packed small tubules and cysts. There are thin fibrous septa separating these tubules and cysts. The tumor cells are simple flat, cuboidal or hobnail cell. The cytoplasm is eosinophilic in most cells, while some cells may show clear cytoplasm. The prominent nucleoli may be one of the important characters in these tumors [6-8,10,12-14]. Immunohistochemically, the tumors share the features of both proximal (CD10 and AMACR) and distal tubules (CK19) [10,11]. Here, we reported a case of TC in a young patient. The gross specimen showed an ill-circumscribed solid tumor, which was atypical for TC. The characters of gross reminded us of angiomyolipoma or small renal cell carcinoma. Howerver, the histopathologic characters supported the diagnosis. The main differential diagnosis in this case was multilocular cystic renal cell carcinoma as this case showed multiple focal clear cells. The characters of nuclear helped us to make the diagnosis. In multilocular cystic renal cell carcinoma, the nuclear showed Fuhrman nuclear grade 1. In TC, the nuclear showed obvious nucleus which showed Fuhrman nuclear grade 3. The significance of the clear cells was not clear. Our case was according with the description above. However, we found some clear cytoplasm cells in our case. As we had a short time follow-up, the significance of these cells was not clear. It needs a long follow-up time to answer this question.

In summary, TC is a new entity of renal cell carcinoma with a distinct macroscopical, microscopical and immunohistochemical characters. The origin of the tumor is not clear. The early researches thought it was a subtype of collecting duct carcinoma CDC, while the recent study considered it may be related to the papillary renal cell carcinoma [2,6]. This tumor should be distinguished from other cystic diseases of the kidney. There is no treatment guideline for this rare tumor. The thorough comprehension of the molecular mechanism in this tumor may help the treatment and management.

References

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Article Usage

  • Total views: 12657
  • [From(publication date):
    February-2015 - Dec 08, 2019]
  • Breakdown by view type
  • HTML page views : 8844
  • PDF downloads : 3813
Top